Julian T. Ross is CEO at OxySure Therapeutics, Inc. (OXYS). They have made 8 open-market trades across 1 company since 2013, most recently 2015-12-31.
CIK 0001528391
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
7 open-market purchases totalling $27K since 2015, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PrivateUnlisted | 16,642,580 | — |
| OXYS | 672,324 | — |
| Total | $0 |
Shares reported on the most recent Form 4, priced at the 2016-03-03 close. 2 holdings could not be priced and are excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OXYS | BUY | 2015-08-04 | 2015-08-14 | $0.41 | $410 | N/A | N/A | N/A |
| OXYS | BUY | 2015-07-29 | 2015-07-29 | $0.45 | $2K | N/A | N/A | N/A |
| OXYS | BUY | 2015-07-23 | 2015-07-24 | $0.50 | $5K | N/A | N/A | N/A |
| OXYS | BUY | 2015-06-04 | 2015-06-04 | $0.66 | $3K | N/A | N/A | N/A |
| OXYS | BUY | 2015-05-28 | 2015-05-29 | $0.69 | $1K | N/A | N/A | N/A |
| OXYS | BUY | 2015-05-27 | 2015-05-27 | $0.68 | $3K | N/A | N/A | N/A |
| OXYS | BUY | 2015-05-26 | 2015-05-26 | $0.67 | $12K | N/A | N/A | N/A |
| OXYS | SELL | 2013-02-11 | 2013-02-13 | $0.63 | $32K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.